GLP‑1 receptor agonists are among the success stories of modern diabetes care. They lower HbA1c, support weight loss, and—depending on the specific drug and the patient’s risk profile—offer addi­tional cardio­me­ta­bolic bene­fits. Nevert­heless, a fami­liar phenomenon…